Calculator May Better Predict the Risk of Death for Patients With Oral Cancer
A newly developed calculator can predict the risk of cancer-specific and all-cause death for patients with oral cancer, according to researchers.
A newly developed calculator can predict the risk of cancer-specific and all-cause death for patients with oral cancer, according to researchers.
This “Clinical Picture” describes a case of extramedullary multiple myeloma manifesting as a rapidly growing intraoral lesion.
The impact of oral squamous cell carcinoma (OSCC) diagnosis and treatment on sexual behavior and relationship stress with respect to HPV status was evaluated in this study. Participants included patients with HPV-positive and HPV-negative disease, as well as partners.
Beverages derived from broccoli sprout extracts were found to have preclinical chemopreventive activity against oral cancer induced by carcinogens.
Quality of life for patients with oral cancer can be dismal due to cancer-related pain. An NIDCR grant is supporting the investigation of a nonviral gene delivery method for treating oral cancer pain safely and effectively.
The prevalence of survivors of oropharyngeal cancer is rising in the United States.
Exclusive smokeless tobacco users demonstrated higher levels of nicotine and carcinogenic tobacco-specific nitrosamines, compared with exclusive cigarette smokers.
A team of scientists has reported that the genetic biomarker LOH is able to predict which patients with premalignant mouth lesions are at highest risk of developing oral cancer. The findings present a new tool that could be used to identify patients most likely to benefit from chemoprevention.
New research reaffirms the association between inflammatory response and the spread of oral cancer.
Elective neck dissection in clinically node-negative early oral squamous cell carcinoma should be considered the standard of care.